>
Pandion Therapeutics Inc logo

PAND - Pandion Therapeutics Inc Share Price

$60.05 0.0  0.0%

Last Trade - 31/03/21

Sector
Healthcare
Size
Mid Cap
Market Cap £1.28bn
Enterprise Value £1.12bn
Revenue £6.35m
Position in Universe th / 6847
Bullish
Bearish
Unlock PAND Revenue
Momentum
Relative Strength (%)
1m -7.86%
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High -4.53%
50d MA
200d MA
Growth & Value
12m Forecast Rolling Industry Market
Valuation (ttm) Industry Market
Margin of Safety
Qualifying GuruScreens
Financial Summary
Year End 31st Dec 2015 2016 2017 2018 2019 2020 2021E 2022E CAGR / Avg
0.000 0.000 0.000 0.000 0.97 8.78 6.42 6.60
PEG
Profitability
ROA
%
%
Cashflow
Dividends
Balance Sheet
NFA
m
FINANCIAL BRIEF: : For the fiscal year ended 31 December 2020, PandionTherapeutics Inc revenues increased from $967K to $8.8M.Net loss applicable to common stockholders increased 66% to$43M. Revenues reflect an increase in demand for theCompany's products and services due to favorable marketconditions. Higher net loss reflects Research anddevelopment increase of 67% to $24.8M (expense).
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

PAND Revenue Unlock PAND Revenue

Net Income

PAND Net Income Unlock PAND Revenue

Normalised EPS

PAND Normalised EPS Unlock PAND Revenue

PE Ratio Range

PAND PE Ratio Range Unlock PAND Revenue

Dividend Yield Range

PAND Dividend Yield Range Unlock PAND Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2021
31st Dec 2022
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2020 /  2021
PAND EPS Forecasts Unlock PAND Revenue
Profile Summary

Pandion Therapeutics, Inc., formerly Pandion Therapeutics Holdco LLC, is a clinical-stage biopharmaceutical company. The Company is focused on developing novel therapeutics designed to address the unmet needs of patients suffering from autoimmune diseases. It is developing its Therapeutic Autoimmune reguLatOry protein (TALON) drug design and discovery platform. Its lead product candidate, PT101, a combination of its interleukin-2 (IL-2), mutein effector module with a protein backbone, is designed to selectively expand regulatory Treg cells, without activating proinflammatory cells, such as conventional T cells and natural killer (NK cells).

Directors
Last Annual December 31st, 2020
Last Interim December 31st, 2020
No. of Shareholders: 87
No. of Employees: 56
Sector Healthcare
Industry Biotechnology & Medical Research
Index
Exchange NASDAQ Global Select Market
Shares in Issue 29,515,583
Free Float (0.0%)
Eligible for
ISAs
SIPPs
PAND Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for PAND
Upcoming Events for PAND
Frequently Asked Questions for Pandion Therapeutics Inc
What is the Pandion Therapeutics Inc share price?

As of 31/03/21, shares in Pandion Therapeutics Inc are trading at $60.05, giving the company a market capitalisation of £1.28bn. This share price information is delayed by 15 minutes.

How has the Pandion Therapeutics Inc share price performed this year?

Shares in Pandion Therapeutics Inc are currently trading at $60.05 and the price has moved by % over the past 365 days. In terms of relative price strength - which takes into account the overall market trend - the Pandion Therapeutics Inc price has moved by % over the past year.

What are the analyst and broker recommendations for Pandion Therapeutics Inc?

There are no analysts currently covering Pandion Therapeutics Inc.

When will Pandion Therapeutics Inc next release its financial results?

Pandion Therapeutics Inc is scheduled to issue upcoming financial results on the following dates:

Interim results are scheduled for: 2021-12-31
What is the Pandion Therapeutics Inc dividend yield?

Pandion Therapeutics Inc does not currently pay a dividend.

Does Pandion Therapeutics Inc pay a dividend?

Pandion Therapeutics Inc does not currently pay a dividend.

When does Pandion Therapeutics Inc next pay dividends?

Pandion Therapeutics Inc does not currently pay a dividend.

How do I buy Pandion Therapeutics Inc shares?

To buy shares in Pandion Therapeutics Inc you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.

What is the market cap of Pandion Therapeutics Inc?

Shares in Pandion Therapeutics Inc are currently trading at $60.05, giving the company a market capitalisation of £1.28bn.

Where are Pandion Therapeutics Inc shares listed? Where are Pandion Therapeutics Inc shares listed?

Here are the trading details for Pandion Therapeutics Inc:

Country of listing: United States
Exchange: NSQ
Ticker Symbol: PAND
What kind of share is Pandion Therapeutics Inc?

We were not able to load our ranking data for Pandion Therapeutics Inc

Is there a Pandion Therapeutics Inc share price forecast 2021?

Shares in Pandion Therapeutics Inc are currently priced at $60.05. At that level they are trading at 0.08% premium to the analyst consensus target price of 0.00.

Analysts covering Pandion Therapeutics Inc currently have a consensus Earnings Per Share (EPS) forecast of -1.573 for the next financial year.

How can I tell whether the Pandion Therapeutics Inc share price will go up?

An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Pandion Therapeutics Inc. Over the past six months, the relative strength of its shares against the market has been 0.344k%. At the current price of $60.05, shares in Pandion Therapeutics Inc are trading at 0.167k% against their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.

What is the Pandion Therapeutics Inc PE Ratio?

We were not able to find PE ratio data for Pandion Therapeutics Inc.

Who are the key directors of Pandion Therapeutics Inc?

We were unable to find the directors for Pandion Therapeutics Inc.

Who are the major shareholders of Pandion Therapeutics Inc?

Here are the top five shareholders of Pandion Therapeutics Inc based on the size of their shareholding:

Polaris Partners Corporation
Percentage owned: 10.85% (3.20m shares)
Versant Ventures Venture Capital
Percentage owned: 10.76% (3.18m shares)
F. Hoffman La Roche, Ltd. Corporation
Percentage owned: 10.46% (3.09m shares)
Access Industries Holdings, L.L.C. Corporation
Percentage owned: 9.58% (2.83m shares)
GlaxoSmithKline PLC Corporation
Percentage owned: 7.66% (2.26m shares)
Similar to PAND
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.